Rose T.

Rose T. is a Senior Research Program Manager at ReCode Therapeutics, specializing in the development of project strategies for Cystic Fibrosis gene editing therapeutics. With previous experience as a Senior Associate Scientist at 23andMe, Rose identified novel drug targets in the cardiometabolic therapeutic area and managed project documentation and timelines. Rose began a career in research as a Graduate student and postdoc researcher at Stanford University School of Medicine, where significant contributions included designing and executing multi-omics datasets to explore genome regulation during drug resistance in melanoma, leading to the identification of key transcription factors. Rose holds a PhD in Cancer Biology from Stanford University School of Medicine.